Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 3
1968 1
1969 1
1970 5
1971 2
1972 2
1973 1
1974 6
1975 2
1976 1
1977 2
1978 4
1979 7
1980 4
1981 7
1982 12
1983 4
1984 9
1985 3
1986 12
1987 8
1988 11
1989 7
1990 14
1991 15
1992 6
1993 4
1994 16
1995 10
1996 12
1997 7
1998 14
1999 18
2000 11
2001 12
2002 10
2003 7
2004 13
2005 11
2006 12
2007 12
2008 16
2009 5
2010 17
2011 16
2012 27
2013 41
2014 39
2015 48
2016 46
2017 56
2018 72
2019 59
2020 55
2021 44
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

798 results
Results by year
Filters applied: . Clear all
Page 1
Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.
Wedzicha JA, Banerji D, Chapman KR, Vestbo J, Roche N, Ayers RT, Thach C, Fogel R, Patalano F, Vogelmeier CF; FLAME Investigators. Wedzicha JA, et al. N Engl J Med. 2016 Jun 9;374(23):2222-34. doi: 10.1056/NEJMoa1516385. Epub 2016 May 15. N Engl J Med. 2016. PMID: 27181606 Free article. Clinical Trial.
Glycopyrronium/Formoterol: A Review in COPD.
Al-Salama ZT, Frampton JE. Al-Salama ZT, et al. Drugs. 2019 Sep;79(13):1455-1466. doi: 10.1007/s40265-019-01186-x. Drugs. 2019. PMID: 31468315 Review.
Pharmacological treatment of COPD - New evidence.
Pires N, Pinto P, Marçal N, Ferreira AJ, Rodrigues C, Bárbara C; GI DPOC Interest Group on Chronic Obstructive Pulmonary Disease. Pires N, et al. Pulmonology. 2019 Mar-Apr;25(2):90-96. doi: 10.1016/j.pulmoe.2018.10.005. Epub 2018 Nov 28. Pulmonology. 2019. PMID: 30502972 Free article. Review.
Glycopyrronium Tosylate (Qbrexza) for Hyperhidrosis.
Nwannunu CE, Limmer AL, Coleman K, Shah R, Patel RR, Mui UN, Tyring SK. Nwannunu CE, et al. Skin Therapy Lett. 2019 Mar;24(2):1-3. Skin Therapy Lett. 2019. PMID: 30970203 Free article. Review.
Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis.
Ferguson GT, Darken P, Ballal S, Siddiqui MK, Singh B, Attri S, Holmgren U, de Nigris E. Ferguson GT, et al. Adv Ther. 2020 Jun;37(6):2956-2975. doi: 10.1007/s12325-020-01311-3. Epub 2020 Apr 25. Adv Ther. 2020. PMID: 32335859 Free PMC article.
▾Glycopyrronium for COPD.
[No authors listed] [No authors listed] Drug Ther Bull. 2013 Jun;51(6):66-8. doi: 10.1136/dtb.2013.6.0184. Epub 2013 Jun 6. Drug Ther Bull. 2013. PMID: 23744364 Review.
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.
Chapman KR, Hurst JR, Frent SM, Larbig M, Fogel R, Guerin T, Banerji D, Patalano F, Goyal P, Pfister P, Kostikas K, Wedzicha JA. Chapman KR, et al. Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339. doi: 10.1164/rccm.201803-0405OC. Am J Respir Crit Care Med. 2018. PMID: 29779416 Free article. Clinical Trial.
798 results